The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001130987.2(DYSF):c.3274_3275del (p.Leu1092fs)

CA915944059

653601 (ClinVar)

Gene: DYSF
Condition: autosomal recessive limb-girdle muscular dystrophy
Inheritance Mode: Autosomal recessive inheritance
UUID: 48fd8804-58c8-4e55-9780-9306c6a60864
Approved on: 2025-01-09
Published on: 2025-01-09

HGVS expressions

NM_001130987.2:c.3274_3275del
NM_001130987.2(DYSF):c.3274_3275del (p.Leu1092fs)
NC_000002.12:g.71574243_71574244del
CM000664.2:g.71574243_71574244del
NC_000002.11:g.71801373_71801374del
CM000664.1:g.71801373_71801374del
NC_000002.10:g.71654881_71654882del
NG_008694.1:g.125621_125622del
ENST00000698057.1:c.646_647del
ENST00000258104.8:c.3220_3221del
ENST00000410020.8:c.3274_3275del
ENST00000258104.7:c.3220_3221del
ENST00000394120.6:c.3223_3224del
ENST00000409366.5:c.3223_3224del
ENST00000409582.7:c.3271_3272del
ENST00000409651.5:c.3316_3317del
ENST00000409744.5:c.3181_3182del
ENST00000409762.5:c.3271_3272del
ENST00000410020.7:c.3274_3275del
ENST00000410041.1:c.3274_3275del
ENST00000413539.6:c.3313_3314del
ENST00000429174.6:c.3220_3221del
NM_001130455.1:c.3223_3224del
NM_001130976.1:c.3178_3179del
NM_001130977.1:c.3178_3179del
NM_001130978.1:c.3220_3221del
NM_001130979.1:c.3313_3314del
NM_001130980.1:c.3271_3272del
NM_001130981.1:c.3271_3272del
NM_001130982.1:c.3316_3317del
NM_001130983.1:c.3223_3224del
NM_001130984.1:c.3181_3182del
NM_001130985.1:c.3274_3275del
NM_001130986.1:c.3181_3182del
NM_001130987.1:c.3274_3275del
NM_003494.3:c.3220_3221del
NM_001130455.2:c.3223_3224del
NM_001130976.2:c.3178_3179del
NM_001130977.2:c.3178_3179del
NM_001130978.2:c.3220_3221del
NM_001130979.2:c.3313_3314del
NM_001130980.2:c.3271_3272del
NM_001130981.2:c.3271_3272del
NM_001130982.2:c.3316_3317del
NM_001130983.2:c.3223_3224del
NM_001130984.2:c.3181_3182del
NM_001130985.2:c.3274_3275del
NM_001130986.2:c.3181_3182del
NM_003494.4:c.3220_3221del
More

Pathogenic

Met criteria codes 4
PVS1 PP4_Strong PM3 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DYSF Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_003494.4: c.3220_3221delCT p.(Leu1074PheTer39) variant in DYSF, which is also known as NM_001130987.2: c.3274_3275del p.(Leu1092PhefsTer39), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 30/55, leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in trans with a pathogenic variant in at least one patient with LGMD (c.1662C>T p.(Arg555Trp), 1.0 pt, PMID: 25591676) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness and absent dysferlin protein expression, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 25591676). This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1, PM3, PP4_Strong, PM2_Supporting.
Met criteria codes
PVS1
The NM_003494.4: c.3220_3221delCT p.(Leu1074PheTer39) variant in DYSF, which is also known as NM_001130987.2: c.3274_3275del p.(Leu1092PhefsTer39), is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 30/55 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PP4_Strong
At least one patient with this variant displayed progressive limb-girdle muscle weakness and absent dysferlin protein expression, which is highly specific for DYSF-associated LGMD (PP4_Strong, PMID: 25591676).
PM3
This variant has been detected in trans with a pathogenic variant in at least one patient with LGMD (c.1662C>T p.(Arg555Trp), 1.0 pt, PMID: 25591676) (PM3).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.